On this episode of Bone Talk, BHOF CEO Claire Gill talks to Dr. Rodrigo Valderrábano. His research focus is on metabolic bone disease and during his time as a research fellow at Stanford University, he was awarded the Endocrine Society’s Outstanding Abstract award and the American Society for Bone and Mineral Research’s Young Investigator award for his work studying the links between bone health and hematopoiesis in older men. He continues his research efforts with the ultimate goal of further delineating treatable risk factors for osteoporosis and devising non-pharmacologic treatment strategies for osteoporosis such as rehabilitation and exercise.